Cargando…

Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection model

OBJECTIVES: Pharmacodynamic profiling of oral ciprofloxacin dosing for urinary tract infections caused by ceftriaxone-resistant Escherichia coli isolates with ciprofloxacin MIC ≥ 0.25 mg/L. BACKGROUND: Urine-specific breakpoints for ciprofloxacin do not exist. However, high urinary concentrations ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abbott, Iain J, van Gorp, Elke, Cottingham, Hugh, Macesic, Nenad, Wallis, Steven C, Roberts, Jason A, Meletiadis, Joseph, Peleg, Anton Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890216/ https://www.ncbi.nlm.nih.gov/pubmed/36473954 http://dx.doi.org/10.1093/jac/dkac402

Ejemplares similares

Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model
por: Abbott, Iain J., et al.
Publicado: (2022)

215. Shorter vs. Longer Duration of Treatment in Patients with Ceftriaxone-resistant and Ceftriaxone-susceptible Escherichia coli Bloodstream Infections
por: Mackow, Natalie A, et al.
Publicado: (2023)

1386. Efficacy of Repeat Dosing of Oral Fosfomycin in a Dynamic Bladder Infection In Vitro Model
por: Abbott, Iain, et al.
Publicado: (2018)

178. Endemic Carbapenem Resistance Driven By Clonal and Horizontal Spread of bla(IMP-4) Across Diverse Enterobacterales: Jumping Genes, Promiscuous Plasmids and Killer Clones
por: Macesic, Nenad, et al.
Publicado: (2021)

Escherichia coli Exopolysaccharides Induced by Ceftriaxone Regulated Human Gut Microbiota in vitro
por: Li, Baiyuan, et al.
Publicado: (2021)

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial
por: Harris, Patrick NA, et al.
Publicado: (2015)

Evolution and transmission of a conjugative plasmid encoding both ciprofloxacin and ceftriaxone resistance in Salmonella
por: Chen, Kaichao, et al.
Publicado: (2019)

Cellular Response to Ciprofloxacin in Low-Level Quinolone-Resistant Escherichia coli
por: Machuca, Jesús, et al.
Publicado: (2017)

Individual and community predictors of urinary ceftriaxone-resistant Escherichia coli isolates, Victoria, Australia
por: Chua, Kyra Y. L., et al.
Publicado: (2019)

1367. Resistance to Ceftriaxone and Ciprofloxacin in Nontyphoidal Salmonella from Humans and Relatedness to Isolates from Animal Sources
por: M’ikanatha, Nkuchia M, et al.
Publicado: (2022)

Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli
por: Dörr, Tobias, et al.
Publicado: (2010)

Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification
por: Mavroidi, Angeliki, et al.
Publicado: (2012)

Increased expression of Qnr is sufficient to confer clinical resistance to ciprofloxacin in Escherichia coli
por: Garoff, Linnéa, et al.
Publicado: (2018)

Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coli
por: Huseby, Douglas L., et al.
Publicado: (2017)

Understanding and predicting ciprofloxacin minimum inhibitory concentration in Escherichia coli with machine learning
por: Pataki, Bálint Ármin, et al.
Publicado: (2020)

Cuminaldehyde potentiates the antimicrobial actions of ciprofloxacin against Staphylococcus aureus and Escherichia coli
por: Monteiro-Neto, Valério, et al.
Publicado: (2020)

Effect of Ciprofloxacin-Loaded Niosomes on Escherichia coli and Staphylococcus aureus Biofilm Formation
por: Maurizi, Linda, et al.
Publicado: (2022)

Pharmacokinetics of ceftriaxone-tazobactam (8:1) combination in healthy and Escherichia coli induced diarrhoeic birds
por: Mithin, U.C., et al.
Publicado: (2022)

Antimicrobial Susceptibility of E. coli Isolates from Intra-Abdominal Infections in the Asia-Pacific Region: Trends in Ciprofloxacin, Ceftriaxone, Cefepime, and Piperacillin/Tazobactam Susceptibility
por: Tsai, Chia-Hung, et al.
Publicado: (2023)

Increasing Spectrum in Antimicrobial Resistance of Shigella Isolates in Bangladesh: Resistance to Azithromycin and Ceftriaxone and Decreased Susceptibility to Ciprofloxacin
por: Mahbubur, Rahman, et al.
Publicado: (2007)

Genomic dissection of endemic carbapenem resistance reveals metallo-beta-lactamase dissemination through clonal, plasmid and integron transfer
por: Macesic, Nenad, et al.
Publicado: (2023)

Dynamics of Quinolone Resistance in Fecal Escherichia coli of Finishing Pigs after Ciprofloxacin Administration
por: HUANG, Kang, et al.
Publicado: (2014)

Pentacyclic triterpenes combined with ciprofloxacin help to eradicate the biofilm formed in vitro by Escherichia coli
por: Wojnicz, Dorota, et al.
Publicado: (2015)

Susceptibility to ciprofloxacin of Escherichia coli strains isolated from patients with chronic kidney disease
por: Ionete, Oana Mariana, et al.
Publicado: (2014)

Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
por: Praski Alzrigat, Lisa, et al.
Publicado: (2017)

Expression of TolC and Organic Solvent Tolerance of Escherichia Coli Ciprofloxacin Resistant Mutants
por: Pourahmad Jaktaji, Razieh, et al.
Publicado: (2017)

Ciprofloxacin, amoxicillin, and aminoglycosides stimulate genetic and phenotypic changes in uropathogenic Escherichia coli strains
por: Adamus-Białek, Wioletta, et al.
Publicado: (2019)

Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms
por: Wang, Lei, et al.
Publicado: (2019)

Effect of RecA inactivation and detoxification systems on the evolution of ciprofloxacin resistance in Escherichia coli
por: Diaz-Diaz, S, et al.
Publicado: (2021)

Evolutionary Instability of Collateral Susceptibility Networks in Ciprofloxacin-Resistant Clinical Escherichia coli Strains
por: Sørum, Vidar, et al.
Publicado: (2022)

Influence of Growth Medium Composition on Physiological Responses of Escherichia coli to the Action of Chloramphenicol and Ciprofloxacin
por: Smirnova, Galina, et al.
Publicado: (2023)

Increase in the community circulation of ciprofloxacin-resistant Escherichia coli despite reduction in antibiotic prescriptions
por: Tchesnokova, Veronika, et al.
Publicado: (2023)

Epidemiology of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae That Are Piperacillin-Tazobactam-Nonsusceptible but Ceftriaxone-Susceptible
por: Baker, Thomas M, et al.
Publicado: (2018)

Clinical Impact of Ceftriaxone Resistance in Escherichia coli Bloodstream Infections: A Multicenter Prospective Cohort Study
por: Tamma, Pranita D, et al.
Publicado: (2022)

Comparison of Infection and Urosepsis Rates of Ciprofloxacin and Ceftriaxone Prophylaxis before Percutaneous Nephrolithotomy: A Prospective and Randomised Study
por: Demirtas, Abdullah, et al.
Publicado: (2012)

230. Nontyphoidal Salmonella from Clinical and Retail Meat Sources Reveal Antimicrobial Resistance Genes for Ceftriaxone and Ciprofloxacin
por: M’ikanatha, Nkuchia M, et al.
Publicado: (2021)

No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia
por: Heng, Shi Thong, et al.
Publicado: (2018)

305. Prevalence of Ceftriaxone Susceptible, Piperacillin-tazobactam Non-susceptible Escherichia coli Bacteremia in Patients with Hematologic Malignancy
por: Spitznogle, Sarah L, et al.
Publicado: (2020)

Antibacterial Derivatives of Ciprofloxacin to Inhibit Growth of Necrotizing Fasciitis Associated Penicillin Resistant Escherichia coli
por: Bartzatt, Ronald, et al.
Publicado: (2013)

Transcriptome Profiling Reveals Interplay of Multifaceted Stress Response in Escherichia coli on Exposure to Glutathione and Ciprofloxacin
por: Goswami, Manish, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dv98356va578suls1fv5njcnrb